PHARMACISTS seeking Recognition of Prior Learning (RPL) for the new Medication Management Review (MMR) Credential should ensure all evidence is submitted by 22 Apr to guarantee processing before interim funding arrangements end on 30 Jun, the Pharmaceutical Society of Australia (PSA) has urged.
From 01 Jul 2025, those who have not obtained a new credential will be unable to claim fees for MMR services when their current Medication Review Numbers (MRNs) will become invalid.
The PSA guarantees that pharmacists who submit a complete MMR RPL application before 22 Apr will have their RPL processed and new credential issued before 01 Jul.
Submissions made after this date will still be processed, but they may not be completed before 1 Jul.
As part of PSA's ongoing support for consultant pharmacists, the society will also continue to provide complimentary MMR RPL for Professional Plus members.
PSA National President Associate Professor Fei Sim said the guarantee gives pharmacists certainty about their ability to continue providing MMR services without interruption.
"I strongly encourage pharmacists who have not yet enrolled in the RPL course and submitted the required evidence to do so as soon as possible," Associate Professor Sim said.
PSA Consultant Pharmacist Community of Specialty Interest Chair Deborah Hawthorne encouraged pharmacists to connect with the CSI for support. KB
Learn more about MMR RPL and the steps you need to take HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 25
